Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
- Author:
Jeong Il YU
1
;
Do Hoon LIM
;
Jeeyun LEE
;
Won Ki KANG
;
Se Hoon PARK
;
Joon Oh PARK
;
Young Suk PARK
;
Ho Yeong LIM
;
Seung Tae KIM
;
Su Jin LEE
;
Sung KIM
;
Tae Sung SOHN
;
Jun Ho LEE
;
Ji Yeong AN
;
Min Gew CHOI
;
Jae Moon BAE
;
Heejin YOO
;
Kyunga KIM
Author Information
- Publication Type:Original Article
- Keywords: Stomach neoplasms; Radiotherapy; Neoplasm staging; Recurrence; Prognosis
- MeSH: Chemotherapy, Adjuvant; Humans; Joints; Methods; Neoplasm Staging; Prognosis; Radiotherapy; Recurrence; Stomach Neoplasms
- From:Cancer Research and Treatment 2019;51(3):876-885
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study was to compare prognostic differentiation performances of the 7th and the 8th edition of American Joint Committee on Cancer (AJCC) staging system for gastric cancer (GC) patients. MATERIALS AND METHODS: A total of 1,633 GC patients who underwent curative D2 resection followed by adjuvant chemotherapy alone (CA) or concurrent chemo-radiotherapy (CCRT) from 2004 to 2013 were included. Concordance index (c-index) was applied to compare the discriminatory ability. RESULTS: In the 8th edition, migration of stage was detected in 248 patients (15.2%). Among them, 121 patients were up-staged while 127 patients were down-staged. Overall, there was no statistically significant difference in the discriminatory ability between the 7th and 8th editions. The new edition of staging system, however, showed a trend of better prognostic performance not only in recurrence-free survival (c-index=0.734; 95% confidence interval [CI], 0.706 to 0.762 in the 7th edition vs. c-index=0.740; 95% CI, 0.712 to 0.768 in the 8th edition; p=0.14), but also in overall survival (c-index=0.717; 95% CI, 0.688 to 0.745 in the 7th edition vs. c-index=0.722; 95% CI, 0.694 to 0.751 in the 8th edition; p=0.19), especially in stage III. This finding was repeated in the subgroup analysis regardless of adjuvant CA or CCRT. CONCLUSION: Generally, the 8th edition of AJCC staging system had failed to show a superior discriminatory ability for curatively D2 resected GC patients than the 7th edition, although there was a trend of better prognostic performance of the new edition, regardless of adjuvant treatment method.
